All elements or requirements outlined in the standard are evident in practice, as indicated by full implementation of the practices outlined in the Practice Standards.
Practices are basically sound but there is room for improvement, as noted in the ratings for the Practice Standards; e.g.,
Minor inconsistencies and not yet fully developed practices are noted; however, these do not significantly impact service quality; or
Procedures need strengthening; or
With few exceptions, procedures are understood by staff and are being used; or
For the most part, established timeframes are met; or
Proper documentation is the norm and any issues with individual staff members are being addressed through performance evaluations and training; or
Active client participation occurs to a considerable extent.
Practice requires significant improvement, as noted in the ratings for the Practice Standards. Service quality or program functioning may be compromised; e.g.,
Procedures and/or case record documentation need significant strengthening; or
Procedures are not well-understood or used appropriately; or
Timeframes are often missed; or
Several client records are missing important information; or
Client participation is inconsistent.
Implementation of the standard is minimal or there is no evidence of implementation at all, as noted in the ratings for the Practice Standards; e.g.,
No written procedures, or procedures are clearly inadequate or not being used; or
Documentation is routinely incomplete and/or missing.
Procedures for evaluating the quality of laboratories
Policies related to toxicology testing
Procedures for toxicology testing
No On-Site Evidence
Interviews may include:
Review case records
Prior to establishing a contract, the organization evaluates the quality of the laboratory to perform drug screens, including use of equipment, methodology, and quality control.
Toxicology specimens are obtained:
with respect for individual privacy; and
in a safe treatment atmosphere.
After the individual's initial admission test, the timing and frequency of toxicology testing is clinically appropriate for each individual, and the opioid treatment program conducts:
at least eight random drug tests per service recipient, per year;
at least one initial and two subsequent tests for individuals in interim maintenance treatment; and
tests, as appropriate, during medically supervised and other types of withdrawal.
Drug testing regimes should be determined based on individual assessment results and by analyzing community drug-use patterns. Testing may include, but not be limited to, opiates, benzodiazepines, barbiturates, cocaine, marijuana, methadone (and its metabolites), amphetamines, and alcohol.
Toxicology testing procedures include, and are not limited to:
informing persons served about how specimens are collected and of their responsibility to provide a specimen when asked;
discussing positive toxicology results with the individual;
providing counseling, medical review, and other interventions if the person continues to test positive for illegal substance use;
methods to minimize falsification during the drug testing sample collection;
a process for reviewing false-positive and false-negative results; and
documenting results in the case record along with the person’s response.
Following the receipt of toxicology test results, the organization:
evaluates negative reports for opioid treatment medication and related metabolites;
reviews dosage when positive toxicology reports for drugs are received;
investigates the possibility of false positive results when persons served deny drug use;
rapidly responds if the individual is found to be in danger of relapse; and
uses the results to determine the need for additional interventions.
Immediate action should be taken to investigate possible diversion of opioid medication when toxicology tests indicate lack of opioids or related metabolites.
Evidence of ongoing drug use is not considered grounds for discharge, unless the individual refuses to cooperate with treatment recommendations.